卡森國際(0496.HK)復牌高開117.58% 今早發澄清公告一一否認做空指稱
格隆匯11月22日丨昨日遭沽空機構BLUE ORCA做空暴跌90%後臨時停牌的卡森國際(0496.HK)今日復牌高開117.58%,開報0.99港元,盤前成交436.49萬港元,最新總市值14.79億港元。BLUE ORCA指:“卡森國際董事長及其家族通過人為低報出售業務的收入和利潤,矇騙投資者洗劫上市公司。Blue Orca強調,最近卡森股價在柬埔寨項目開發公告以及中國住宅銷售的盈利推動下大漲,但兩者未來都不會為投資者提供太多價值,並且公司在柬埔寨的投資可能只是虛張聲勢。”今早,卡森國際發出澄清公告,一一否認殺人鯨資本所有指稱,詳情見下列鏈接:
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.